JPWO2019236703A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019236703A5 JPWO2019236703A5 JP2020567578A JP2020567578A JPWO2019236703A5 JP WO2019236703 A5 JPWO2019236703 A5 JP WO2019236703A5 JP 2020567578 A JP2020567578 A JP 2020567578A JP 2020567578 A JP2020567578 A JP 2020567578A JP WO2019236703 A5 JPWO2019236703 A5 JP WO2019236703A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- document
- application publication
- patent application
- prior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024056596A JP2024096738A (ja) | 2018-06-05 | 2024-03-29 | 悪性リンパ腫性障害の治療法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862680739P | 2018-06-05 | 2018-06-05 | |
| US62/680,739 | 2018-06-05 | ||
| PCT/US2019/035576 WO2019236703A1 (en) | 2018-06-05 | 2019-06-05 | Methods of treating malignant lymphoproliferative disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024056596A Division JP2024096738A (ja) | 2018-06-05 | 2024-03-29 | 悪性リンパ腫性障害の治療法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021527039A JP2021527039A (ja) | 2021-10-11 |
| JP2021527039A5 JP2021527039A5 (https=) | 2022-06-13 |
| JPWO2019236703A5 true JPWO2019236703A5 (https=) | 2022-06-13 |
| JP7794564B2 JP7794564B2 (ja) | 2026-01-06 |
Family
ID=68769443
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020567578A Active JP7794564B2 (ja) | 2018-06-05 | 2019-06-05 | 悪性リンパ腫性障害の治療法 |
| JP2024056596A Pending JP2024096738A (ja) | 2018-06-05 | 2024-03-29 | 悪性リンパ腫性障害の治療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024056596A Pending JP2024096738A (ja) | 2018-06-05 | 2024-03-29 | 悪性リンパ腫性障害の治療法 |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11510904B2 (https=) |
| EP (1) | EP3801768A4 (https=) |
| JP (2) | JP7794564B2 (https=) |
| KR (1) | KR20210045364A (https=) |
| CN (2) | CN112351819B (https=) |
| AU (1) | AU2019280693B2 (https=) |
| BR (1) | BR112020024931A2 (https=) |
| CA (1) | CA3102555A1 (https=) |
| IL (2) | IL279155B2 (https=) |
| MX (2) | MX2020013163A (https=) |
| WO (1) | WO2019236703A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112351819B (zh) * | 2018-06-05 | 2023-11-10 | 开动疗法公司 | 治疗恶性淋巴增生性疾病的方法 |
| AU2020415440A1 (en) * | 2019-12-26 | 2022-08-04 | Actuate Therapeutics, Inc. | Compounds for the treatment of myelofibrosis |
| WO2022109057A1 (en) * | 2020-11-17 | 2022-05-27 | Brown University | Inhibition of glycogen synthase kinase-3 (gsk-3) |
| JP2022157223A (ja) * | 2021-03-31 | 2022-10-14 | 国立大学法人神戸大学 | 抗ガン剤効果増強剤 |
| CN113684180B (zh) * | 2021-08-31 | 2023-05-26 | 山东大学第二医院 | 一种提高骨髓瘤杀伤活性的nk细胞制备方法 |
| WO2023172629A2 (en) * | 2022-03-08 | 2023-09-14 | Brown University | Anticancer maleimide derivatives for use with immune checkpoint blockade |
| US20250325517A1 (en) * | 2022-06-27 | 2025-10-23 | Actuate Therapeutics, Inc. | Oral dosage forms of elraglusib |
| US20260060969A1 (en) * | 2022-08-04 | 2026-03-05 | Institut National de la Santé et de la Recherche Médicale | Methods for the treatment of lymphoproliferative disorders |
| WO2025245059A1 (en) * | 2024-05-23 | 2025-11-27 | Yale University | Compositions comprising gsk-3 and/or beta-catenin inhibitors and/or degraders and methods of use thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2673368C (en) | 2006-12-19 | 2014-10-28 | The Board Of Trustees Of The University Of Illinois | 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders |
| CA2860250C (en) | 2012-02-21 | 2020-11-10 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |
| JP6321662B2 (ja) | 2012-10-12 | 2018-05-09 | ザ ブロード インスティテュート, インコーポレーテッドThe Broad Institute, Inc. | Ｇｓｋ３阻害剤およびその使用の方法 |
| US20160375006A1 (en) * | 2012-10-12 | 2016-12-29 | The Broad Institute, Inc. | Uses of paralog-selective inhibitors of gsk3 kinases |
| WO2014165851A1 (en) * | 2013-04-05 | 2014-10-09 | The Children's Hospital Of Philadelphia | Transient up-regulation of myc in b-cell lymphomas |
| US20170165230A1 (en) | 2014-04-09 | 2017-06-15 | Christopher Rudd | Use of gsk-3 inhibitors or activators which modulate pd-1 or t-bet expression to modulate t cell immunity |
| JP6534098B2 (ja) * | 2014-09-12 | 2019-06-26 | 国立大学法人 鹿児島大学 | 成人ｔ細胞白血病治療薬 |
| CN112351819B (zh) * | 2018-06-05 | 2023-11-10 | 开动疗法公司 | 治疗恶性淋巴增生性疾病的方法 |
-
2019
- 2019-06-05 CN CN201980037210.9A patent/CN112351819B/zh active Active
- 2019-06-05 WO PCT/US2019/035576 patent/WO2019236703A1/en not_active Ceased
- 2019-06-05 CN CN202311356900.5A patent/CN117883438A/zh active Pending
- 2019-06-05 US US15/734,699 patent/US11510904B2/en active Active
- 2019-06-05 BR BR112020024931-9A patent/BR112020024931A2/pt not_active Application Discontinuation
- 2019-06-05 IL IL279155A patent/IL279155B2/en unknown
- 2019-06-05 IL IL315565A patent/IL315565A/en unknown
- 2019-06-05 EP EP19815715.8A patent/EP3801768A4/en not_active Withdrawn
- 2019-06-05 AU AU2019280693A patent/AU2019280693B2/en active Active
- 2019-06-05 JP JP2020567578A patent/JP7794564B2/ja active Active
- 2019-06-05 CA CA3102555A patent/CA3102555A1/en active Pending
- 2019-06-05 KR KR1020207037918A patent/KR20210045364A/ko not_active Ceased
- 2019-06-05 MX MX2020013163A patent/MX2020013163A/es unknown
-
2020
- 2020-12-03 MX MX2024008461A patent/MX2024008461A/es unknown
-
2022
- 2022-11-03 US US18/052,369 patent/US11980607B2/en active Active
-
2024
- 2024-03-29 JP JP2024056596A patent/JP2024096738A/ja active Pending
- 2024-04-09 US US18/630,283 patent/US20240366563A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021527039A5 (https=) | ||
| JPWO2019236703A5 (https=) | ||
| Attner et al. | The role of human papillomavirus in the increased incidence of base of tongue cancer | |
| NO20080362L (no) | CD19-antistoffer og deres anvendelser | |
| JPWO2019229543A5 (https=) | ||
| NO20081987L (no) | Humane, monoklonale antistoffer mot CD70 | |
| JP2018525453A5 (https=) | ||
| NO20064866L (no) | IRTA-5 antistoffer og deres anvendelse | |
| Mohammadi et al. | In silico identification of two novel viruses on Iranian pistachio | |
| JPWO2020172525A5 (https=) | ||
| JPWO2020041083A5 (https=) | ||
| Mégret et al. | Unconventional sintering of a commercial cemented WC-6Co hardmetal | |
| Bossu et al. | HYbrid PROduction of Pellets-based (PIM-MIM-CIM) Additive Manufactured parts-HyProPAM | |
| 이치현 et al. | Improving Compaction in LSM Tree by Applying Simple Copy to Key-Value Separated LSM-Tree | |
| Ergot et al. | Severe nuclear compression triggers DNA damage and cell cycle arrest | |
| Seyyar et al. | Further notes on a little known spider species, Zelotes strandi (Araneae: Gnaphosidae) from Anatolia. | |
| LIEBL | 08_PH1080_-_Genesis_I, _1-2-sample. mp3 | |
| JP2019536015A5 (https=) | ||
| LIEBL | 35_PH3195_-_Conseja-sample. mp3 | |
| LIEBL | 06_PH1078_-_Zionist_hymn-sample. mp3 | |
| LIEBL | 19_PH3179_-_Riddles-sample. mp3 | |
| LIEBL | 05_PH1077_-_Moralistic_Song-sample. mp3 | |
| LIEBL | 01_PH1073_-_Romance-_Landarico-sample. mp3 | |
| LIEBL | 22_PH3180_-_Dialogue-sample. mp3 | |
| LIEBL | 18_PH3178_-_Proverbs-sample. mp3 |